factual
Regulators Have Data But Default to Two RCTs
Regulators like the FDA can access large amounts of patient-level data that never reaches publication, but in practice they typically approve when two positive RCTs are found rather than using the full data to guide decisions.
factualpending
Speaker
Jacob StegengaEvidence Quote
“regulators can get access to this data. And, in an ideal world, they would be able to use that data, in a way that guided their regulatory decisions... Yeah. Exactly. So, the typical practice is to approve when there is--the two positive RCTs that are found.”
Created: 6/13/2026, 12:09:58 AM
Your notes
Loading notes...